PMID: 8947334Nov 1, 1996Paper

Allergic bronchial asthma: eosinophil chemotaxis and antihistaminic drug modulation

Allergy
M T VenturaA Tursi

Abstract

This paper investigated the chemotactic capacity of blood eosinophils (EOS) in response to C5a and formyl-leucyl-phenylalanine (FMLP) in 15 Parietaria-pollen-allergic patients with mild asthma during the Parietaria pollen season. Data showed that EOS chemotaxis toward C5a was significantly reduced during the peak pollen count, compared with the values obtained in normal subjects. On the other hand, FMLP could induce EOS chemotactic activity only in Parietaria-allergic patients, the highest value being registered during the height of the Parietaria season. In vitro cimetidine modulation of chemotactic function in comparison with C5a led to a recovery of the impaired results obtained in the presence of high histamine levels. Moreover, diphenhydramine preincubation of EOS induced a reduction of the enhanced chemotactic activity obtained with low concentrations. The data suggest that different serum histamine levels give rise to an impaired immune-phlogistic response in allergic patients and that histamine-receptor antagonists may modulate this effect.

References

Dec 1, 1975·The Journal of Experimental Medicine·R A ClarkA P Kaplan
Feb 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H Smith
May 1, 1991·The Journal of Clinical Investigation·D Y LeungR S Cotran
Aug 1, 1989·The Journal of Allergy and Clinical Immunology·P Rafferty, S T Holgate
May 1, 1989·The Journal of Allergy and Clinical Immunology·L HåkanssonP Venge
Oct 1, 1988·The Journal of Allergy and Clinical Immunology·P McBrideM Kaliner
Jun 1, 1987·Thorax·K J Taylor, A R Luksza
Sep 1, 1985·Clinical Allergy·S R Durham, A B Kay
Nov 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·R SnydermanM H Hausman
Jan 1, 1983·Clinical Allergy·P W IndC T Dollery
Jun 1, 1993·The Journal of Allergy and Clinical Immunology·R A WarringaL Koenderman
Jan 1, 1987·Immunology Today·D S Silberstein, J R David

❮ Previous
Next ❯

Citations

May 10, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Gordon D RaphaelHoward M Druce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.